NsGene Raises $3 Million In Second Round
10/19/2005 5:09:39 PM
NsGene is a developer of novel cell and gene based products for the treatment of neurological diseases. The company concentrates on developing treatments that are based on neural transplantation of naked or encapsulated cells or vectors capable of tran...
comments powered by